{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["55(8)"],"submitter":["Maze MJ"],"funding":["Ministry of Health, New Zealand"],"pubmed_abstract":["<h4>Background</h4>Pacific region-specific data on the clinical course of COVID-19 are limited. We aimed to describe clinical features and outcomes from Aotearoa New Zealand patients, focusing on Māori and Pacific peoples.<h4>Methods</h4>We conducted a retrospective cohort study among adults (≥16 years) hospitalised due to COVID-19 at 11 hospitals from January to May 2022. We included all Māori and Pacific patients and every second non-Māori, non-Pacific (NMNP) patient using data from chart review and national datasets.<h4>Results</h4>Of 2319 patients, 582 (25%) were Māori, 914 (39%) Pacific peoples and 862 NMNP (median age 52, 57 and 63 years respectively). Vaccination coverage (≥2 doses) was 73.4% (n = 437) for Māori, 76.7% (n = 701) for Pacific peoples (n = 701) and 84.8% (n = 731) for "],"journal":["Internal medicine journal"],"pagination":["1339-1349"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC12347309"],"repository":["biostudies-literature"],"pubmed_title":["Variation in clinical presentation, complications and outcomes for Maori and Pacific peoples among hospitalised adults with COVID-19 in 2022, Aotearoa New Zealand."],"pmcid":["PMC12347309"],"pubmed_authors":["Hancox RJ","Selak V","Ritchie S","Wright K","Bhally H","Hassan R","Storer M","Murdoch DR","Best E","Raymond N","Dummer J","Wong C","Webb R","Maze MJ","Walls T","Epton M","McArthur C","Chang C","Goodson J","Chen K","Rodgers H","Williman J","Good W","Morpeth S","Pylypchuk R","Hills T","Hotu S","Grimwade K","Bryce A","Grey C","Pease F","Ryan D","Anstey R"],"additional_accession":[]},"is_claimable":false,"name":"Variation in clinical presentation, complications and outcomes for Maori and Pacific peoples among hospitalised adults with COVID-19 in 2022, Aotearoa New Zealand.","description":"<h4>Background</h4>Pacific region-specific data on the clinical course of COVID-19 are limited. We aimed to describe clinical features and outcomes from Aotearoa New Zealand patients, focusing on Māori and Pacific peoples.<h4>Methods</h4>We conducted a retrospective cohort study among adults (≥16 years) hospitalised due to COVID-19 at 11 hospitals from January to May 2022. We included all Māori and Pacific patients and every second non-Māori, non-Pacific (NMNP) patient using data from chart review and national datasets.<h4>Results</h4>Of 2319 patients, 582 (25%) were Māori, 914 (39%) Pacific peoples and 862 NMNP (median age 52, 57 and 63 years respectively). Vaccination coverage (≥2 doses) was 73.4% (n = 437) for Māori, 76.7% (n = 701) for Pacific peoples (n = 701) and 84.8% (n = 731) for ","dates":{"release":"2025-01-01T00:00:00Z","publication":"2025 Aug","modification":"2026-05-01T18:45:07.003Z","creation":"2026-04-07T17:09:36.198Z"},"accession":"S-EPMC12347309","cross_references":{"pubmed":["40543063"],"doi":["10.1111/imj.70114"]}}